Molecular Microbiology Research Group, Murdoch Children’s Research Institute, Melbourne, Australia
Glenda Fehler
Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia
Christopher K. Fairley
Central Clinical School, Monash University, Melbourne, Australia
Dieter M. Bulach
Microbiological Diagnostic Unit Public Health Laboratory, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia
Suzanne M. Garland
Molecular Microbiology Research Group, Murdoch Children’s Research Institute, Melbourne, Australia
Recurrence of BV following standard treatment is unacceptably high. Posttreatment recurrence is distressing for women, and it imposes a considerable burden on the health care system.